The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...

The Simplici-T ® Annuloplasty System offers a first-of-its-kind approach to mitral and tricuspid valve repair. It is the first flexible band to eliminate the need for traditional sizing ...

Patients with arrhythmogenic mitral valve prolapse syndrome are at increased risk for life-threatening ventricular arrhythmias, but studies have been limited by small sample sizes. We sought to ...

Dr. Vijay S. Iyer, MD, Ph.D., FACC, is a distinguished interventional cardiologist specializing in complex cardiac and ...

The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...